
501 - 1000 employees
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that develops RNA interference (RNAi)-based therapeutics to silence disease-causing genes and treat intractable, often intractable, cardiometabolic and pulmonary disorders. Using a portfolio of RNA chemistries and delivery technologies, Arrowhead aims to induce rapid, deep, and durable knockdown of target genes to address conditions such as hypertriglyceridemia, dyslipidemia, cardiovascular disease, and various pulmonary diseases.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 September 1
Associate Director managing payer and PBM accounts for Arrowhead Pharmaceuticals’ RNAi medicines. Translating formulary, claims, and specialty pharmacy data into market access strategy.
🕒 June 25
Medical Science Liaison developing scientific engagement with healthcare professionals in cardiometabolic diseases. Engaging in clinical support and sharing insights in a dynamic environment.